The concept of sublingual film dosage form has become popular as new delivery system. This system will provide maximum therapeutic efficacy, increased bioavailability and maximum stability by reducing the frequency of dosage. It will also avoid first pass metabolism of the drugs. This system provides more rapid drug absorption from the pre gastric area which may provide quick onset of action. The present research aimed to prepare sublingual films of apixaban reduces the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. The film was prepared using solvent casting method and optimized employing 3 2 factorial design considering two independent variables film forming polymer (HPMC E5) and PEG 400. Disintegration time, drug release and folding endurance were taken as dependent variables. The prepared optimized formulation showed minimum disintegration time (35 s), highest dissolution rate (99 %) and satisfactory physicochemical properties. It is evident from the above results that the developed formulation can be an innovative dosage form to improve the drug delivery, onset of action as well as improve patient compliance.
INTRODUCTION

Introduction of Drug Delivery System
Introduction of Sublingual Drug Delivery
 [ 
1-4]
The term sublingual plainly means 'under the tongue'. It refers to a method of administering drug substances via mouth in such a way that the drug substances are rapidly absorbed in systemic circulation via highly vascularized sublingual route in the oral mucosa rather than digestive tract. Dysphagia (difficulty in swallowing) is a common problem of all age groups, especially elderly, children, and patients who are mentally retarded, uncooperative, nauseated or on reduced liquid intake diets have difficulties in swallowing these dosage forms. Sublingual administration of the drug means placement of the drug under the tongue and drug reaches directly in to the blood stream.
Mouth dissolving film/Sublingual films is a thin film with an area of 5-20 cm2 containing an active ingredient. The immediate dissolution, in water or saliva respectively, is reached through a special matrix from water-soluble polymers. A typical composition contains the following: 
Active pharmaceutical agent
The drugs selected for oral films should possess good stability in saliva and water with low dose. The film should consist of 1-25% w/w of the drug. Small dose molecules are the best candidates to be incorporated in Oral fast dissolving film. Multi vitamin sup to 10% w/w of dry film weight was incorporated in the films with dissolution time of less than 60 seconds. It is always useful to have micronized API which will improve the texture of the film and also for better dissolution and uniformity in the Oral fast dissolving film.
Film forming polymer
A variety of polymers are available for preparation of fast dissolving films. The polymers can be used alone or in combination to obtain the desired films properties. The films obtained should be tough enough so that there won't be any damage while handling or during transportation. The robustness of the strip depends on the type of polymer and the amount in the formulation The polymers can be used alone or in combination to obtain the desired strip properties. Water-soluble polymers are used as film formers. The use of film forming polymers in dissolvable films has attracted considerable attention in medical and nutraceutical application. The water-soluble polymers achieve rapid disintegration, good mouth feel and mechanical properties to the films. The disintegration rate of the polymers is decreased by increasing the molecular weight of polymer film base. Both natural as well as synthetic polymers can be used in the formulation of sublingual films. In order to prepare a film formulation that is water-soluble, excipients or polymer must be water soluble with low molecular weight and excellent film forming capacity. At least 45% w/w of polymer should generally be present based on the total weight of dry film but typically 60-65%w/w of polymer is preferred to obtained desired properties. The polymer employed should be non-toxic, non-irritant and devoid of leachable impurities. It should have good wetting and spread ability property. The polymer should exhibit sufficient peel, shear and tensile strengths.The various natural as well as synthetic polymers to make fast dissolving films include cellulose or cellulose derivatives, pullulan, gelatin, hypromellose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl pyrrolidone, carboxymethyl cellulose, polyvinyl alcohol, sodium alginate, xanthan gum, tragacanth gum and guar gum. Pullulan is a natural polymer obtained from nonanimal origin and does not require chemical modification.
Plasticizers
It helps to improve the flexibility of the strip and reduces the brittleness of the strip. Plasticizer significantly improves the strip properties by reducing the glass transition temperature of the polymer. Glycerol, propylene glycol ,low molecular weight propylene glycols, phthalate derivatives like dimethyl, diethyl and dibutyl phthalate ,citrate derivatives such as tributyl ,triethyl, acetyl citrate, triacetin and castor oil are some commonly used plasticizer excipients. Typically the plasticizers are used in the concentration of 0-20% w/w of the dry polymer weight.
Saliva stimulating agent
The purpose of using saliva stimulating agents is to increase the rate of production of saliva that would aid in the faster disintegration of the rapid dissolving strip formulations .These agents are used alone or in combination between 2-6% w/w of the strip. Citric acid, malic acid, lactic acid, ascorbic acid and tartaric acid are the few examples of salivary stimulants.
Sweetening agents
Sweeteners have become the important part of pharmaceutical products intended to be disintegrated or dissolved in the oral cavity. The classical source of sweetener is sucrose, dextrose, fructose, glucose, liquid glucose and isomaltose .Polyhydric alcohols such as sorbitol, mannitol and isomalt can be used in combination as they additionally provide good mouth feel and cooling sensation. The artificial sweeteners like Saccharin, cyclamate and aspartame are the first generation of the artificial sweeteners followed by acesulfame-k, sucralose, alitame and neotame which fall under the second generation artificial sweeteners. Generally sweeteners are used in the concentration of 3 to 6 %w/w either alone or in combination.
Flavouring agents
Preferably up to 10%w/w flavors are added in the Fast dissolving film formulations The acceptance of the oral disintegrating or dissolving formulation by an individual is largely depends on the initial flavor quality which is observed in first few seconds after the product has been consumed and the after taste of the formulation which lasts for at least about 10 min. The geriatric population like mint or orange flavors while younger generation like flavors like fruit punch, raspberry etc. Flavoring agents can be selected from the synthetic flavor oils, oleo resins, extracts derived from various parts of plants like leaves, fruits and flowers. Any flavor can be added such as essential oils or water soluble extracts of menthol, intense mints such as peppermint, sweetmint, spearmint, wintergreen, cinnamon, clove, sour fruit flavor such as lemon, orange or sweet confectionary. Flavors such as vanillin, chocolate or fruit essence like apple, raspberry, cherry, pineapple.
Coloring agents
A full range of colors is available including FD&C colors, EU colors, natural coloring agents and natural juice concentrates, pigments such as titanium dioxide, silicon dioxide and zinc oxide and custom pantone matched colors.
Manufacturing Methods: -[11, 12]
Following processes can be used to manufacture fast dissolving films: 
Solvent casting method
In solvent casting method water soluble polymers are dissolved in water and the drug along with other excipients is dissolved in suitable solvent then both the solutions are mixed and stirred and finally casted in to the Petri plate, dried and cut in to uniform dimensions.
Semi solid casting method
In semisolid casting method firstly a solution of water-soluble film forming polymer is prepared. The resulting solution is added to a solution of acid insoluble polymer (e.g. cellulose acetate phthalate, cellulose acetate butyrate), which was prepared in ammonium or sodium hydroxide. Then appropriate amount of plasticizer is added so that a gel mass is obtained. Finally the gel mass is casted in to the films or ribbons using heat controlled drums. The thickness of the film is about 0.015-0.05 inches. The ratio of the acid insoluble polymer to film forming polymer should be 1:4.
Hot melt extrusion method
In hot melt extrusion method firstly the drug is mixed with carriers in solid form. Then the extruder having heaters melts the mixture. Finally the melt is shaped in to films by the dies.
There are certain benefits of hot melt extrusion.
 Fewer operation units
 Better content uniformity  An anhydrous process
Solid dispersion extrusion
In this method immiscible components are extrude with drug and then solid dispersions are prepared. Finally the solid dispersions are shaped in to films by means of dies.
Rolling method
In rolling method a solution or suspension containing drug is rolled on a carrier. The solvent is mainly water and mixture of water and alcohol. The film is dried on the rollers and cut in to desired shapes and sizes.. 
Introduction of Drug
Absorption
Apixaban is absorbed in the stomach and small intestine. For doses up to 10 mg, the absolute bioavailability is about 50%.
Bioavailability
%
Protein binding 87 %
Metabolism Hepatic
Half life
If administered orally, the half life is 12 hours (due to prolonged absorption). If administerd by I.V., the half-life is about 5 hours.
Excretion
About 27% of total Apixaban is renally cleared.
Pharmacological Properties:-
Indication
Apixaban is to lessen the danger of stroke and foundational embolism in patients with nonvalvular atrial fibrillation. It has likewise been utilized to bring down the danger of creating venous thrombosis post-orthopedic surgeries. Hypromellose is widely used in oral, ophthalmic, nasal, and topical pharmaceutical formulations. In oral products, hypromellose is primarily used as a tablet binder, in film-coating, and as a matrix for use in extended release tablet formulations. Concentrations between 2% and 5% w/w may be used as a binder in either wet-or drygranulation processes. High-viscosity grades may be used to retard the release of drugs from a matrix at levels of 10-80% w/w in tablets and capsules. Citric acid (as either the monohydrate or anhydrous material) is widely used in pharmaceutical formulations and food products, primarily to adjust the pH of solutions. It has also been used experimentally to adjust the pH of tablet matrices in enteric-coated formulations for colon-specific drug delivery. Citric acid monohydrate is used in the preparation of effervescent granules, while anhydrous citric acid is widely used in the preparation of effervescent tablets.(2-4) Citric acid has also been shown to improve the stability of spray-dried insulin powder in inhalation formulations. In food products, citric acid is used as a flavor enhancer for its tart, acidic taste. Citric acid monohydrate is used as a sequestering agent and antioxidant synergist.
Aspartame
Synonyms BP: Aspartame PhEur: Aspartamum USPNF: Aspartame Chemical Name and CAS Registry Number Aspartame is used as an intense sweetening agent in beverage products, food products, and table-top sweeteners, and in pharmaceutical preparations including tablets, powder mixes and vitamin preparations. It enhances flavor systems and can be used to mask some unpleasant taste characteristics; the approximate sweetening power is 180-200 times that of sucrose. Unlike some other intense sweeteners, aspartame is metabolized in the body and consequently has some nutritive value: 1 g provides approximately 17 kJ (4 kcal). However, in practice, the small quantity of aspartame consumed provides a minimal nutritive effect. Therapeutically, aspartame has also been used in the treatment of sickle cell anemia.
LITERATURE REVIEW
Review of Literature on Drug Delivery System
Rajni B et al [19] prepared fast dissolving films (FDF) of aprepitant used in the prevention and treatment of chemotherapy-induced nausea and vomiting. The FDF was prepared using solvent casting method and optimized employing central composite design considering two independent variables film forming polymer (pullulan) and PEG 400. Disintegration time, wetting time, drug release and folding endurance were taken as dependent variables. The prepared optimized formulation showed minimum disintegration time (20 s), highest dissolution rate (88.87%) and satisfactory physicochemical properties. It is evident from the above results that the developed formulation can be an innovative dosage form to improve the drug delivery, onset of action as well as improve patient compliance. [20] developed Terbutaline sulfate fast dissolving sublingual films were prepared using seven drug compatible film formers in different combinations and proportions. The film polymers are maltodextrin, Na alginate, Carpabol 430, xanthan gum, HPMC E5, PVP K-25, and Na CMC. Propylene glycol and sorbitol were used as plasticizers and mannitol as filler. The optimum polymer concentrations and the plasticizer amount were selected on the basis of flexibility, tensile strength, and stickiness of the films. The prepared films were evaluated for their tensile strength, thickness uniformity, disintegration time (in vitro and in vivo), in vitro dissolution, and moisture content. Polymer type rather than total polymer concentration or plasticizer amount showed a significant effect on the tested film properties. A randomized, single dose, crossover study was conducted in four healthy volunteers to compare the pharmacokinetic profile of terbutaline sulfate from the prepared films and the conventional oral tablets. The film formula of choice gave a significantly faster drug absorption rate and recorded a relative bioavailability of 204.08%. Sublingual films could be promising as a convenient delivery system for terbutaline sulfate in patients with swallowing problems. The improved extent of absorption (higher AUC (0-24)) indicates success in improving drug bioavailability, and the faster absorption rate could be promising for the management of acute episodes of asthma. [21] formulate and evaluate oral thin films for sublingual administration of Amlodipine besylate. Amlodipine besylate is a calcium channel blocker used in the treatment of hypertension, angina and other cardiovascular diseases. Films were formulated using HPMC (15cps, 60cps), PVA, and HPC as different film-forming agents (3 and 4% (w/v)). Poly ethylene glycol 400 was used as plasticizer and SSG as disintegrant. Sodium saccharine was used to mask the bitter taste of the drug. Films were prepared by solvent casting method and evaluated for drug content, disintegration time, thickness, tensile strength, folding endurance and % cumulative drug released. The optimized formulation (HPMC 15 cps) F5 exhibited acceptable folding endurance (95), disintegration time (33 sec) and drug release of 98.5% in 360 sec. It can be concluded from the study that the Amlodipine oral thin films for sub lingual administration can be a potential novel drug dosage form.
Soha S et al
Ramya D et al
Rakesh K et al [22] developed fast dissolving oral film of terbutaline sulphate using HPMC K15 LV as film forming polymer. The films were prepared by solvent casting method. Optimization of HPMC E15 LV, SSG and PEG-400 was carried out using 23 full factorial designs. The formulated films of terbutaline sulphate were evaluated for their physico-mechanical parameters like disintegration time, tensile strength, percent elongation, folding endurance and In-vitro drug release. Estimation of drug content uniformity of terbutaline sulphate films was performed and the results were satisfactory. Optimized batch F6 has thickness (0.254±0.01mm), disintegration time (19.90±0.42 sec.) tensile strength (2.95±0.09 Mpa), % Elongation (18.95±0.12), Folding endurance (153±7.0), CPR1min 35.16±4.56% and CPR10min 80.29±4.15%. [23] formulate the Fast dissolving oral films (FDOF) of Diazepam an anti epileptic drug which is normally administered by intramuscular route or as rectal suppository in acute conditions of seizure emergencies. Oral films were prepared by solvent casting method using HPMC E3, E5, and E15 as a film formers and propylene glycol, PEG 400 as plasticizers and evaluated for mechanical properties, disintegration and in vitro dissolution. All formulations showed good mechanical properties and in vitro drug release. The optimized (F4A) Formulation (HPMC E5 and PEG 400) Exhibited drug release of 99.89% in 15 minutes which was significantly high when compared to marketed tablet valium (68.81%). [24] worked on Sumatriptan succinate which is a 5-HT1 receptor agonist which is used in the treatment of migraine. It shows low bioavailability (15%) due to high hepatic first pass metabolism. The present work intended to formulate mucoadhesive sublingual films of sumatriptan combined with metoclopramide and sumatriptan alone with the objective of improving the therapeutic efficacy, patient compliance, and bioavailability. The sublingual films were formulated by solvent casting technique using mucoadhesive polymer of hydroxypropyl methylcellulose and propylene glycol as plasticizers. This study was also designed to evaluate the physicochemical and mucoadhesive characteristics of the films. The films were evaluated for their mechanical strength, folding endurance, drug content uniformity, swelling, in vitro residence time, in vitro release, in vitro bioadhesion, and in vivo mucoadhesion. They showed good appearance and elasticity. The best drugs of polymer ratio were S3 (1:2) and SM2 (2.7:1:8). The film of S3 and SM2 showed 10.6 and 11.01 mg weight, 2.2 and 22.5 µm thickness, 300 folding endurance, 55.9 and 100% content uniformity, respectively. The Differential Scanning Calorimetry (DSC) showed no stable sample of sumatriptan and metoclopramide in the drug loaded films and revealed amorphous form and transition of hydrate to anhydrous form for metoclopramide. The results showed that the films prepared were fast dissolving. The films (sumatriptan combined with metoclopramide and sumatriptan alone) exhibited very good mucoadhesive properties and shorter retention time (15-30 s). The formulations were found to be suitable candidates for the development of sublingual films for therapeutic uses.
Ali M et al
Maryam M et al
Viviana D et a [25] Administered by an oral route, Furosemide (FUR), a diuretic used in several edematous states and hypertension, presents bioavailability problems, reported as a consequence of an erratic gastrointestinal absorption due to various existing polymorphic forms and low and pH-dependent solubility. A mucoadhesive sublingual fast-dissolving FUR based film has been developed and evaluated in order to optimize the bioavailability of FUR by increasing solubility and guaranteeing good dissolution reproducibility. The Differential Scanning Calorimetry (DSC) analyses confirmed that the film prepared using the solvent casting method entrapped FUR in the amorphous state. As a solid dispersion, FUR increases its solubility up to 28.36 mg/mL. Drug content, thickness, and weight uniformity of film were also evaluated. The measured Young's Modulus, yield strength, and relative elongation of break percentage (EB%) allowed for the classification of the drug-loaded film as an elastomer. Mucoadhesive strength tests showed that the force to detach film from mucosa grew exponentially with increasing contact time up to 7667 N/m 2 . FUR was quickly discharged from the film following a trend well fitted with the Weibull kinetic model. When applied on sublingual mucosa, the new formulation produced a massive drug flux in the systemic compartment. Overall, the proposed sublingual film enhances drug solubility and absorption, allowing for the prediction of a rapid onset of action and reproducible bioavailability in its clinical application.
Review of Literature on Drug
Gambhire M et al [26] prepared and evaluated immediate release Apixaban tablets which contains super disintigrants via direct compression, to improve disintegration, dissolution and to get faster onset of action. Super disintigrants used in this formulation are microcrystalline cellulose and cross carmellose sodium, sodium starch glycolate.
Pravalika P et al [27] developed a simple, accurate and precise UV Spectrophotometric method for determination of Apixaban in bulk and pharmaceutical formulations. The optimum conditions for the analysis of drug are established and Apixaban is found to exhibit maximum absorption at 282 nm with DMSO as a solvent. The present method is validated as per guidelines of the International Conference on Hormonization (ICH) guidelines including parameters like linearity, accuracy, and precision, limit of detection and limit of quantification.
Dudhe P et al
[28] developed a simple, new, precise and reproducible two UV -spectrophotometric methods for the estimation of Apixaban in bulk and tablet dosage form. Methanol was used as a solvent to prepare standard and sample solutions.  RATIONAL OF PATENT Above five patents describes different formulation of Apixaban in different dosage form. No any patented work done on Apixaban sublingual films of. The principle of Apixaban sublingual films preparation offers a simple and practical approach to achieve quick onset of action for the dosage form and bypass the hepatic first pass effect of drug which ultimately improves bioavailability. Hence the selected title is novel and appropriate.
Summary of PSAR Report
AIM & OBJECTIVES
Aim of Work
"Formulation and Evaluation of Sublingual Films of Apixaban"
Rationale
 Apixaban is an oral, direct, and highly selective factor Xa (FXa) inhibitor for the prevention and treatment of thromboembolic diseases.  Apixaban is to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It has also been used to lower the risk of developing venous thrombosis postorthopedic surgical procedures.  Its recommended oral dose is 2.5/5 mg/day.  Apixaban is belongs from BCS class III drug which has high solubility and low permeability.  Half life is 12 hours.  Its Log P is 1.83 and Molecular weight is 459.49 g/mol.  Bioavailability of Apixaban is approximately 50% due to Hepatic first pass metabolism.  So its low molecular weight, high solubility and hepatic first pass effect makes it a good candidate for immediate release type of sublingual dosage form.  By giving sublingual route, quick onset of action will achieved which requires in stroke condition and also by pass the hepatic first pass metabolism.
Objectives of Work
 To check Drug: Excipients compatibility study by FTIR.  To formulate Sublingual films of Apixaban having size of 2x2 cm 2 using film casting polymers by solvent casting method.  To optimize the amount of polymer and Plasticizer in Films.  To achieve disintegration time within 60 sec.  To achieve more than 90 % drug release within 10 min in drug release study.
To perform accelerated stability study of films. 
MATERIALS AND EQUIPMENTS
List of Materials
List of Equipments
Preformulation Study
Characterization of drug
By checking its visual Description, odour and solubility's in various solvents according to described in Indian Pharmacopeia monograph.
Drug-Excipients compatibility
FTIR Study
The FTIR of pure drug and optimized film was measured using Fourier transform infrared spectrophotometer. The pure drug and optimized film were separately mixed with IR grade KBr. This sample was scanned over a wavelength range of 4000 to 400 cm -1 .
DSC Study
The DSC of pure drug and optimized film was measured using Differential scanning calorimeter. Melting point of drug should be check and compared.
Determination of λ max and Standard Curve of Apixaban
Standard calibration curve of Apixaban was prepared using 6.8 phosphate buffer solutions. Weighed amount of drug 10 mg was added to 6.8 phosphate buffer. Further dilution was done with the help of same solvent. 5, 10, 15, 20, 25 and 30 µg/ml concentration solutions were prepared and absorption was taken at 279 nm in UV spectroscopy. Standard curve was plotted by taking concentration on X-axis and absorbance on Y-axis.
Calculation of the dose of Apixaban
Diameter of the Petridish = 9 cm Radius = Diameter /2 = 9/2 = 4.5 cm.
Area of petridish = πr 2 = 3.14 X 4.5 X 4.5 = 63.585 cm 
Method of Preparation
Solvent Casting Method:
 The solvent casting method was used for the preparation of the film.  Take required amount of drug and then dissolve it in Water.  Take required amount of film forming polymer and dissolve in water.  Mix both the solution with continuous stirring and then uniformly dispersed to get clear solution of film forming polymer.
 After that required amount of plasticizer to be added to film forming solution.  Other ingredients & sweetener were dissolved one by one in previously prepared film forming solution with constant stirring to form clear solution.  The Prepared solution was kept in undisturbed condition till the entrapped air bubbles were removed.  The aqueous solution was casted in a glass petridish having area of 63.58 cm 2 and was dried at room temperature.  The petridish were put on the leveled surface during drying to avoid variation in the thickness.  The film took approximately 24 hours to dry at room temperature.  The dried film was carefully removed from the mould and was cut into size required for testing. The films were stored in airtight plastic bags till further use. Trial batches of Apixaban sublingual films were initiated with different grade of HPMC polymer. Three grade of HPMC polymer namely E3, E5 and E15 selected as they were widely used polymer in film formulations for fast drug release. These grades were different with respect to their viscosity grade. PEG 400 used as a plastsizer and citric acid used for saliva stimulation. Aspartame was used for sweetening purpose. Sufficient amount of water used for film casting as it was not present in final formulation. Approximately 30.0 ml water was used in all formulation.
Formulation development of Apixaban sublingual films
Application of 3 2 Full Factorial Design for formula optimization
It is desirable to develop an acceptable pharmaceutical formulation in shortest possible time using minimum number of man-hours and raw materials. Traditionally pharmaceutical formulations are developed by changing one variable at a time approach. The method is time consuming in nature and requires a lot of imaginative efforts. Moreover, it may be difficult to develop an ideal formulation using this classical technique since the joint effects of independent variables are not considered. It is therefore very essential to understand the complexity of pharmaceutical formulations by using established statistical tools such as factorial design. In addition to the art of formulation, the technique of factorial design is an effective method of indicating the relative significance of a number of variables and their interactions. Where Y is the dependent variable, b 0 is the arithmetic mean response of the nine runs and bi is the estimated coefficient for the factor X i . The main effects (X 1 and X 2 ) represent the average result of changing one factor at a time from its low to high value. The interaction terms (X 1 X 2 ) show how the response changes when two factors are simultaneously changed. The polynomial equation can be used to draw conclusion after considering the magnitude of coefficient and the mathematical sign it carries, i.e., positive or negative. The high values of correlation coefficient for the dependent variables indicate a good fit. The equation 1 may be used to obtain estimate of the response because small error of variance was noticed in the replicates. 
Evaluation of Apixaban sublingual films
Films should be stiff, flat and should not curl on the edges. The Sublingual film strip must be robust enough to be removed from the unit-dose packaging and to be handled by the consumer without breaking. The film must also dissolve readily in order to deliver the active agent rapidly when placed in the oral cavity. Mechanical property of fast dissolving film plays an important role in deciding all these things. Therefore, the mechanical property of fast dissolving film is as important as its solubility rate. So the prepared sublingual films were evaluated for the following parameters:
Weight Variation
Four centimeter square (2 X 2 cm) of the film was cut at three different places from the casted film. The weight of each film was taken and weight variation was calculated.
Thickness
Randomly 3 films were selected and thickness was measured using a digital vernier caliper (Mitutoyo, Japan).
Measurement of in vitro disintegrating
The disintegration time was measured (n=3) for film of each batch in 10 ml of simulated saliva (pH 6.8) in glass petri dish. Film sample (2 cm x 2 cm) was placed in 10 ml of simulated saliva. The time for complete solubilization of the film was recorded as disintegration time. The average of three measurements was taken into consideration.
Measurement of Mechanical Properties
The mechanical property of the film gives idea about to what extent the film can withstand the force or stress during processing, packaging, transport and handling. The measurement of mechanical properties gives an indication of the strength and elasticity of the film, reflected by the parameters, i.e. tensile strength, % elongation and folding endurance. A suitable film should have a relatively moderate tensile strength, high % elongation at break but a low elastic modulus.
Mechanical properties of films like Tensile Strength measured by texture analyzer. A small film strip (2 cm X 2 cm) was cut and fixed to assembly. Each test strip was placed in tensile grips on the texture analyzer. Speed 1mm/s. The force in Newton required to break the film was noted and simultaneously film elongation was measured with the help of pointer mounted on the assembly. Measurements were done in triplicate for each batch. Three mechanical properties namely tensile strength, % elongation and folding endurance of films were evaluated.
 Tensile Strength
Tensile strength is the maximum stress applied to a point at which the film specimen breaks. The tensile strength (TS) can be calculated by dividing the maximum load by the original cross-sectional area of the specimen and it is expressed in force per unit area (N/mm 2 ).
Tensile strength = Load at failure
Strip thickness × Strip width
 Percent Elongation at break (%E)
When stress is applied, a film sample stretches, and this stress is referred to as strain. Strain is basically the deformation of the film divided by the original dimension of the sample. As the plasticizer content increases, the elongation of film is observed.
Percentage elongation = Increase in length of strip x 100
Initial length of strip
 Folding Endurance
Folding endurance was determined by repeatedly folding the film at the same place until it break. The numbers of times the film can be folded at the same place without breaking give the value of folding endurance.
Drug content
The film unit (n=3) of the dimensions 2 cm× 2 cm was placed in 100 ml of simulated salivary fluid. After complete solubilization, the solution was diluted appropriately, filtered and analyzed by UV method. The average of three films was taken as the content of drug in one film unit.
In Vitro Dissolution Study
Dissolution study of sublingual films was carried out using USP type I (Basket apparatus) with 300 ml of simulated salivary fluid (pH 6.8) as dissolution medium maintained at 37 ± 0.5°C. Medium was stirred at 50 rpm. Samples were withdrawn at every 2 min interval, replacing the same amount with the fresh medium. Amount of drug in the withdrawn samples was determined by UV spectrophotometer. The percent drug released was plotted against time.
Surface pH
The surface pH of film was determined in order to investigate the possibility of any side effect in vivo. As an acidic or alkaline pH may cause irritation of the oral mucosa, it was determined to keep the surface pH as close to neutral as possible. A combined pH electrode was used for this purpose. Oral film was slightly wet with the help of water. The pH was measured by bringing the electrode in contact with the surface of the oral film. The procedure was performed in triplicate and average with standard deviation was reported.
Swelling Index
Simulated saliva solution is used to check the swelling studies of films. Initial weight of film is determined and is placed in petri dish containing 10 ml simulated saliva. Increase in film weight is noted at predetermined time interval until no further increase in weight.
Degree of swelling = Final weight -Initial weight Initial Weight
Stability Study
Stability study was carried out at 45°C/ 75% RH conditions. Each piece of the films of formulation was packed in butter paper followed by aluminum foil and plastic tape. After 1 month, the films were evaluated for the physical appearance, disintegration time, drug content and in vitro drug release.
RESULTS AND DISCUSSION
Preformulation Study
Characterization of drug
First of all after receiving a sample of drug we have to check out the basic characteristic of API which is given in below table. Results of Preformulation study for Apixaban are shown in table 8. Drug was found to be freely soluble in methanol and in water, so solvent casting method can be used for Film Preparation.
Compatibility Study by FTIR
The spectra of the selected formula with the pure drug had shown all the characteristic peaks of the drug, from which we conclude the stable nature of the drug during the process. Characteristics peaks obtained for the pure drug correlated well with that of the formulation peaks. This indicated that the drug was compatible with the formulation components. 
Compatibility Study by DSC
DSC study of pure drug and the final formulation performed to check the compatibility between drug and final formulation excipients. The pure drug peak match with the final formulation peak and hence the drug was found compatible with the selected excipients. Pure drug melting point found 237.39 °C and in formulation it was 237.54 °C. Both values were within the reference data 235-238 °C. 
Scanning for λmax of Apixaban
Scanning for λmax of Apixaban done using 6.8 phosphate buffers. After scanning for over a range of 400-200 nm on a double beam UV Spectrophotometer, solution of Apixaban of showed maximum absorbance at 279.
Figure 3 Scanning for λmax of Apixaban
Calibration Curve of Apixaban
Standard calibration curve of Apixaban was prepared using 6.8 phosphate buffer solution. Standard curve was plotted by taking concentration on X-axis and absorbance on Y-axis. 
Evaluation of Prepared Films of trial batches
Trial Batches of Blank Film
Initial trials were taken for finalization of polymers. The prepared films of trial batches were evaluated for basic evaluation parameters. The results were recorded below in tabulated form. From the above results it can be concluded that the HPMC E3 polymer did not form a good film. The films were sticky in nature and poor quality. HPMC E5 and E15 make good and average films respectively.
Further some physical and chemical parameters were checked for polymer selection point of view. Weight variation was well within acceptable range. Folding endurance of all formulation checked and recorded. Folding endurance was depending on amount of polymer and flexibility of films. Thickness found uniform in all formulations. For F1 and F2 batches, some of tests were not performed as the films were not form properly. Hence these two batches were omitted from evaluation. F3 and F4 batches found good with respect to disintegration time and folding endurance. F4 batch have a high value of folding endurance. F5 and F6 batch have higher DT time than the HPMC E5 polymer batches. Hence F4 batch was selected for further screening and factorial design purpose. F4 have a low DT value and good folding endurance. Also the films of F4 batches were non sticky and flexible which was the actual requirement of the formulation.
Evaluation of Prepared sublingual Films factorial batches
Factorial batches A1-A9 was evaluated for various parameters like weight variation, thickness, Surface pH, Swelling Index, Drug Content, Disintegration time, Folding endurance, % Elongation, Drug release and Tensile strength which were given in below table. 
Figure 5 Drug release study of factorial batches
In preliminary phase, attention was given to select the proper concentration of film forming agent to develop successful sublingual films. These selections were used to impart suitable ductility, mechanical strength and flexibility to the films under different type of mechanical stress. HPMC E5 was used as a film forming agent due to its excellent film forming properties. PEG 400 was selected as plasticizer for HPMC E5 based sublingual films as it developed clear homogenous preparation. The films prepared by using combination of HPMC E5 and PEG 400 found to be flexible with good mechanical strength. Preliminary trials indicated 100-200 mg of HPMC E5 and 5 ml plasticizer level in the film casting solution showed good results for mechanical properties and disintegration time. Levels of other excipients were fixed for all formulations. The selected levels of both factors were optimized using design expert software. 3 2 central composite design enabled prediction of interaction among independent variables and its effect on the dependent variables. It was helpful to investigate that how the response changes when two factors are changed simultaneously. Therefore 3 2 central composite design was used to prepare apixaban loaded films. The in vitro release of the drug was found to be 99% in 15 min indicating that the films dissolve within 15 minutes and the formulation excipients did not retain the drug. The results of drug content indicated that drug has been uniformly distributed in the film. The drug content of optimized formulation was found to be 97.8%. As no significant difference in drug content was found which indicated good content uniformity among the films. 6.6 Statistical Analysis of factorial design To generate optimized formulation, different equations and regression behaviors were analyzed and fitted into the Minitab 16 software. Figure 18 Overlay counter plot  Validation of optimized formulation A checkpoint batch was designed accordance to the desirability function. To assess the validity of prediction, a checkpoint batch A10 and A11 was prepared and evaluated under the same conditions as outlined for the other batches. The response data was compared with that of required data. 
Figure 20 Comparison with marketed product
Based on above data it concluded that the formulation of sublingual films were faster as compared to marketed product.
Stability Study
Stability study of final optimized batch A12 performed for 1 month at 40°C and 75% RH. Initial results and after 1 month results compared and found satisfactory. The batch was found stable during stability. The results were recorded in below table. 
